Healthcare -
Biotechnology - NASDAQ - US
$ 41.1
1.61 %
$ 2.66 B
Market Cap
-17.56
P/E
KYMR - TOTAL LIABILITIES & EQUITY
Total Liabilities & Equity KYMR - Kymera Therapeutics, Inc.
576 M
LAST VALUE
-2.52%
2 YEAR CAGR
67.07%
5 YEAR CAGR
0.00%
10 YEAR CAGR